Search results
Results from the WOW.Com Content Network
On May 22, the House Armed Services Committee approved its version of the 2025 National Defense Authorization Act, by a 57–1 vote. [6] As passed by the Committee, the bill included the Pentagon's controversial "Legislative Proposal 480", transferring Air National Guard space units to the Space Force; however, the Committee accepted an amendment proposed by Joe Wilson (R‑SC), watering down ...
The National Defence Academy and Naval Academy Examination is an entrance examination conducted by the Union Public Service Commission (UPSC) twice a year for admissions into the National Defence Academy (NDA) and Indian Naval Academy (INA). [1] The NDA Exam serves as a gateway for candidates seeking a career in the Indian Army, Navy, and Air ...
(January 2025) (Learn how and when to remove this message) Republicans vigorously opposed the anti-extremism working group created by Secretary of Defense Lloyd Austin . That working group had been created by Austin after it became apparent that some service members and veterans had participated in the attack on the US Capitol January 6, 2021 .
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
In December 2024 and January 2025, Quoin announced positive data from the mid-point and at completion of 12 weeks of testing the first subject dosed twice-daily in Quoin’s ongoing open-label study which demonstrated evidence of clear improvement across all measured clinical endpoints.
The House bill H.R. 7900 was passed on July 14, 2022. [1] Hearings on the Senate amendment in the House Committee on Rules were scheduled for December 4. On December 6, a political agreement was reached between the leaders of the Senate Armed Services Committee and House Armed Services Committee . [ 1 ]
The National Defense Authorization Act for Fiscal Year 2017 law also authorizes "Department of Energy national security programs", benefits for military personnel and their families, and includes "authorities to facilitate" ongoing international operations for the Fiscal Year 2017.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced that its ongoing rolling Biologics License Application (BLA) submission to the FDA for lifileucel is expected to be completed in the first ...